Showing results (751-760 of 3,565) with videos related to
Sort By:
Pageof 357
Journal of Thrombosis and Thrombolysis|January 22, 2008
Improving adjunctive treatment in pulmonary embolism and fibrinolytic therapy. The role of enoxaparin and weight-adjusted unfractionated heparinCarlos Jerjes-Sánchez, Sergio Villarreal-Umaña, Alicia Ramírez-Rivera, et al.Journal of Thrombosis and Thrombolysis|April 10, 2020
Left atrial appendage closure: a balanced management of the thromboembolic risk in patients with hemophilia and atrial fibrillationMarco Toselli, Davide Bosi, Giorgio Benatti, et al.Journal of Thrombosis and Thrombolysis|April 13, 2020
The Impact of platelet-fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery diseaseJae Seok Bae, Jong-Hwa Ahn, Jeong Yoon Jang, et al.Journal of Thrombosis and Thrombolysis|October 24, 2019
Pharmacodynamic assessment of prasugrel and clopidogrel in patients with non-cardioembolic stroke: a multicenter, randomized, active-control clinical trialTakenori Yamaguchi, Toshiaki Shirai, Satoshi Yoshiba, et al.Journal of Thrombosis and Thrombolysis|May 24, 2015
Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocolJessica Kepplinger, Alexandra Prakapenia, Kristian Barlinn, et al.Journal of Thrombosis and Thrombolysis|July 16, 2016
Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activationKarl Egan, Audrey Dillon, Eimear Dunne, et al.Journal of Thrombosis and Thrombolysis|March 11, 2023
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapyM Berteotti, A M Gori, B Giusti, et al.Journal of Thrombosis and Thrombolysis|April 23, 2015
Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individualsBongani B Nkambule, Glenda Davison, Hayley IppJournal of Thrombosis and Thrombolysis|April 24, 2015
Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INRFaiza Yasmeen, Muhammad Bilal Ghafoor, Abdul Wadood Khalid, et al.Journal of Thrombosis and Thrombolysis|February 16, 2010
Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptorsMilan Popović, Svetlana Paskas, Maja Zivković, et al.Pageof 357